Navigation Links
Rest for the Weary: Pain Relief for Diabetics with Painful Neuropathy

WALTHAM, Mass., Nov. 5, 2013 /PRNewswire/ -- Way back in the 17th century, John Donne, English attorney, cleric and preeminent representative of the metaphysical poets, wrote: "Sleep is pain's easiest salve, as doth fulfill all offices of death, except to kill." Today, those words could especially resonate with the estimated three to five million U.S. men and women with Type 2 diabetes who suffer from Painful Diabetic Neuropathy (PDN), as half of them report trouble falling or remaining asleep.

PDN is a manifestation of diabetic neuropathy, a common complication of diabetes that results from nerve damage due to high blood glucose (sugar) levels. PDN can bring about symptoms such as burning, stabbing and hypersensitivity in the feet, and can severely limit patients' daily functions.

Unfortunately, even when treated with pain medications, only one in four patients with PDN reports 50 percent relief. Furthermore, PDN is non-discriminatory, in that it lasts through the night. Given the difficulty these patients can already experience in their daily routines, what can be done to help relieve their pain while they sleep? And perhaps even provide daytime pain relief as well?

Fortunately, one innovative company understands the importance of Donne's sentiments, especially for PDN patients. That company is NeuroMetrix, Inc., a medical device company headquartered in Waltham, Massachusetts, focused on the neurological complications of diabetes. Its team, led by Chief Executive Officer Shai N. Gozani, M.D., Ph.D., has created the SENSUS™ Pain Management System, to help those who suffer from PDN find rapid, non-narcotic pain relief both while awake and during sleep—or "pain's easiest salve," as Donne would say.

As Dr. Gozani explains, "The sleep cycle is essential for the repair, rebuilding and recharging of the human body and its natural systems. For the millions who are afflicted with PDN, pain symptoms can actually worsen at nighttime, according to studies published in medical journals."

SENSUS is a lightweight, wearable transcutaneous electrical nerve stimulation (TENS) device that provides fast-acting pain relief as a complement to pain medications. It's the first such device to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use during sleep.

For more on how to manage PDN with SENSUS, ask your doctor, or visit, which paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
2. Treating Poison Ivy Is A Snap! New Cortizone 10 Poison Ivy Relief Pads Launch Just In Time For Summer
3. BioElectronics Enters Malaysias Pain Relief Market
4. BioElectronics Unique Pain Relief Product Featured on Leading Healthcare Show in Spain
5. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
6. Timely Analysis of Pain Relief Costs and Outcomes Finds Disproportionate Risks for Seniors
7. Breakthrough Procedure Provides Relief for Acid Reflux
8. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
9. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at
10. Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. North America Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Other
Post Your Comments:
(Date:11/25/2015)... -- Today AVACEN Medical announced the issue of United States patent No. 9,192,509 ... This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods of ... Photo - ... ... ...
(Date:11/25/2015)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... CEO, will discuss corporate updates at the 27 th ... on Wednesday, December 2, 2015 at 1 p.m. ... and then the link to the event. Participants should allow ... visit the site and download any streaming media software needed ...
(Date:11/25/2015)... November 25, 2015 --> ... blood glucose devices was valued at $11,171.1 million in ... CAGR of 5.7% during 2015 - 2022. The global ... increasing prevalence of diabetes. In addition, the increase in ... also contributing to the growth of the market. Furthermore, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... ... DMG Productions announced that they will feature Aphria, Inc., in an upcoming episode ... and show times TBA. , Aphria, Inc., is a publicly traded company incorporated under ... medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). , Aphria ...
(Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... organization will waive paid entry and parking fees at several of their most ... Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. The ...
Breaking Medicine News(10 mins):